Product Description
Tesamorelin | 10mg
Researching Growth Hormone Signaling and Metabolic Regulation
What It Does
Tesamorelin is a modified growth hormone-releasing hormone (GHRH) analog being studied for its role in stimulating endogenous growth hormone release and regulating metabolic pathways. It is a focus in research exploring visceral fat metabolism, insulin sensitivity, and endocrine signaling.
What Researchers Explore
- Growth hormone release and pituitary signaling
- Visceral fat metabolism and distribution
- Insulin sensitivity and glucose regulation
- Lipid metabolism and cardiometabolic markers
- Body composition and fat redistribution
- Cognitive and endocrine signaling pathways
Technical Background
Tesamorelin is a 44-amino acid analog of GHRH with an N-terminal modification (trans-3-hexenoic acid) that increases resistance to enzymatic degradation, extending its half-life compared to native GHRH. This allows for sustained stimulation of growth hormone release.
It binds to GHRH receptors on pituitary somatotroph cells, promoting GH secretion and downstream IGF-1 activity. Research has explored its effects on metabolic parameters, including visceral adiposity and glucose regulation, through prolonged endocrine signaling.
Common Research Applications
- Sustained GH secretion and endocrine signaling research
- Visceral fat metabolism and distribution studies
- Insulin sensitivity and glucose control research
- IGF-1 pathway activation studies
- Peptide modification and pharmacokinetics research
- Comparative studies with native GHRH analogs
Product Properties
Purity: 99%+ HPLC
Form: Lyophilized Powder
Size: 10mg
Category: Growth Hormone Research
Frequently Studied Together
- CJC-1295 NO DAC (GHRH analog research)
- Ipamorelin (GH secretagogue research)
- Sermorelin (pituitary signaling research)